drugset / Trial / NCT01492972

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

NCT01492972

Phase 3 Recruiting 192 enrolled Proton Collaborative Group
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effects, good and/or bad of two treatment methods on subjects and their cancer. Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen suppression is not completely understood. This study will compare the use of hypofraction proton therapy (28 treatments) alone to proton therapy with androgen suppression therapy.

Timeline

Start
2012-01
Primary completion
2027-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Goserelin Other / unclassified
Subject Leuprolide Other / unclassified
Subject Triptorelin Other / unclassified
Subject buserelin Unknown

Indications